Sills Eric Scott, Qublan Hussein S, Blumenfeld Zeev, Dizaj Ahmad Vt, Revel Ariel, Coskun Serdar, Jaoude Imad Abou, Serour Gamal, Eskandar Mamdoh, Khalili Mohammad Ali, Demirol Aygul, Trokoudes Krinos, Ocal Pelin, Sultan Abdul Munaf, Lotto Benjamin A, El-Kareh Adele
Reproductive Endocrinology Division, Department of Obstetrics and Gynecology, Vassar Brothers Medical Center, Poughkeepsie, New York, USA.
J Exp Clin Assist Reprod. 2007 Aug 28;4:3. doi: 10.1186/1743-1050-4-3.
This research describes current clinical and demographic features sampled from reproductive endocrinology programs currently offering in vitro fertilization (IVF) in the Middle East.
Clinic leadership provided data via questionnaire on patient demographics, demand for IVF services, annual cycle volume, indications for IVF, number of embryos transferred, twinning frequency, local regulations governing range of available adjunct therapies, time interval between initial enrollment and beginning IVF as well as information about other aspects of IVF at each center.
Data were received from representative IVF clinics (n = 13) in Cyprus, Egypt, Iran, Israel, Jordan, Lebanon, Qatar, Saudi Arabia and Turkey. Mean (+/- SD) age of respondents was 47.8 +/- 8 yrs, with average tenure at their facility of 11.2 +/- 6 yrs. Estimated total number of IVF programs in each nation responding ranged from 1 to 91. All respondents reported individual participation in accredited CME activity within 24 months. 76.9% performed embryo transfers personally; blastocyst transfer was available at 84.6% of centers. PGD was offered at all sites. In this population, male factor infertility accounted for most IVF consultations and the majority (59.1%) of female IVF patients were < 35 yrs of age. Prevalence of smoking among female IVF patients was 7.2%. Average number of embryos transferred was 2.4 (+/- 0.4) for patients at age < 35 yrs, and 2.9 (+/- 0.8) at age > 41 yrs. For these age categories, twinning (any type) was observed in 22.6 (+/- 10.8)% and 13.7 (+/- 10.4)%, respectively. In 2005, the average number of IVF cycles completed at study sites was 1194 (range 363-3500) and 1266 (range 263-4000) in 2006. Frozen embryo transfers accounted for 17.2% of cycles at these centers in 2005. Average interval between initial enrollment and IVF cycle start was 8 weeks (range 0.3-3.5 months).
This sampling of diverse IVF clinics in the Middle East, believed to be the first of its kind, identified several common factors. Government registry or oversight of clinical IVF practice was limited or nonexistent in most countries, yet number of embryos transferred was nevertheless fairly uniform. Sophisticated reproductive health services in this region are associated with minimal delay (often < 8 weeks) from initial presentation to IVF cycle start. Most Middle East nations do not maintain a comprehensive IVF database, and there is no independent agency to collect transnational data on IVF clinics. Our pilot study demonstrates that IVF programs in the Middle East could contribute voluntarily to collaborative network efforts to share clinical data, improve quality of care, and increase patient access to reproductive services in the region.
本研究描述了从中东地区目前提供体外受精(IVF)的生殖内分泌项目中抽取的当前临床和人口统计学特征。
各诊所负责人通过问卷提供了有关患者人口统计学、IVF服务需求、年度周期数量、IVF适应症、移植胚胎数量、双胎妊娠频率、可用辅助治疗范围的当地法规、初次登记与开始IVF之间的时间间隔以及每个中心IVF其他方面信息的数据。
收到了来自塞浦路斯、埃及、伊朗、以色列、约旦、黎巴嫩、卡塔尔、沙特阿拉伯和土耳其的代表性IVF诊所(n = 13)的数据。受访者的平均(±标准差)年龄为47.8 ± 8岁,在其机构的平均任职年限为11.2 ± 6年。每个做出回应的国家中估计的IVF项目总数在1至91个之间。所有受访者均报告在24个月内个人参加了经认可的继续医学教育活动。76.9%的人亲自进行胚胎移植;84.6%的中心提供囊胚移植。所有中心均提供植入前基因诊断(PGD)。在该人群中,男性因素不孕症占大多数IVF咨询病例,大多数(59.1%)女性IVF患者年龄小于35岁。女性IVF患者中的吸烟率为7.2%。年龄小于35岁的患者平均移植胚胎数量为2.4(±0.4)个,年龄大于41岁的患者为2.9(±0.8)个。对于这些年龄组,分别观察到22.6(±10.8)%和13.7(±10.4)%的双胎妊娠(任何类型)。2005年,研究地点完成的IVF周期平均数量为1194个(范围363 - 3500个),2006年为1266个(范围263 - 4000个)。2005年,这些中心的冷冻胚胎移植占周期的17.2%。初次登记与IVF周期开始之间的平均间隔为8周(范围0.3 - 3.5个月)。
中东地区不同IVF诊所的此次抽样调查,据信是同类调查中的首次,确定了几个共同因素。大多数国家对临床IVF实践的政府登记或监督有限或不存在,但移植胚胎数量却相当一致。该地区复杂的生殖健康服务与从初次就诊到IVF周期开始的最小延迟(通常<8周)相关。大多数中东国家没有维护全面的IVF数据库,也没有独立机构收集有关IVF诊所的跨国数据。我们的试点研究表明,中东地区的IVF项目可以自愿为合作网络努力做出贡献,以共享临床数据、提高护理质量并增加该地区患者获得生殖服务的机会。